Liem G S, Cornelissen J J, Oudshoorn M, Sintnicolaas K, Löwenberg B, Hagenbeek A
Academisch Ziekenhuis Rotterdam-Daniel, Hoed Kliniek, afd. Hematologie.
Ned Tijdschr Geneeskd. 1997 Aug 9;141(32):1553-6.
A female patient aged 37 years who suffered from chronic myeloid leukemia received an allogeneic bone marrow transplantation (BMT) from an HLA-matched unrelated donor. No life-threatening complications ensued; 2.5 years after BMT she is still in complete remission. Survival after BMT from an unrelated donor for the time being is still lower than that after BMT from a related donor, but is improving due to better prevention and treatment of opportunistic infections and better selection of registered donors by meticulous HLA matching.